Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01701674
Title Ipilimumab With Lymphodepletion Plus Adoptive Cell Transfer and High Dose IL-2 in Melanoma Mets Pts
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors H. Lee Moffitt Cancer Center and Research Institute
Indications

melanoma

Therapies

Cyclophosphamide + Fludarabine

Ipilimumab

Aldesleukin

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
H. Lee Moffitt Cancer Center and Research Institute Tampa Florida 33612 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field